Base title: NCI's genomic characterization center to title: DNA whole genome sequencing (WGS) for new CCG studies period of performance 09/01/2020 - 08/31/2023 fully funded - non-severable services
Ended Awarded Last action
- Contract number
- 75N91020F00001
- Awardee
-
The Broad Institute, Inc. UEI H5G9NWEFHXN4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,677,314
Award facts
- Contract value 100% obligated
- $2,677,314.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02142, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$719,712 | |
| Other Administrative Action | -$279 | |
| Other Administrative Action | $0 | |
| Original award | $3,397,305 |
About this award
The National Cancer Institute awarded a delivery order valued at $2.68 million to The Broad Institute, Inc. for DNA whole genome sequencing services supporting new Cancer Genomics Consortium studies. The contract, which commenced September 1, 2020 and was initially scheduled to conclude August 31, 2023, operates under the NCI Genomic Characterization Centers master indefinite delivery contract as a parent vehicle. Performance will be conducted in Cambridge, Massachusetts, with firm fixed-price pricing and no set-aside designation applied. A bilateral modification executed in March 2025 descoped and deobligated $719,711.74 from the task order as part of the President's Department of Government Efficiency cost efficiency initiative, with an ultimate completion date extended to August 31, 2025.
The Broad Institute, a non-profit biomedical research organization jointly affiliated with MIT and Harvard University, specializes in genomics and precision medicine services. The institute brings substantial experience in large-scale genomic sequencing and data analysis, supported by its recognition as a critical federal research partner across multiple National Institutes of Health institutes and centers. This contract contributes to the NCI's broader cancer genomics research portfolio, enabling researchers to characterize tumor genomes and identify genetic drivers of cancer through comprehensive whole genome sequencing capabilities.
Quick answers
Who was awarded contract 75N91020F00001?
75N91020F00001 was awarded to The Broad Institute, Inc. by National Cancer Institute (National Institutes of Health) on September 1, 2020.
How much is contract 75N91020F00001 worth?
The government has obligated $2,677,314 on 75N91020F00001.
Is contract 75N91020F00001 an order under another contract?
Yes. 75N91020F00001 is a delivery order under 75N91019D00029, an indefinite delivery contract, on NCI Genomic Characterization Centers.
Was contract 75N91020F00001 competed?
The extent of competition for 75N91020F00001 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award